What Researchers Did
Researchers measured eye and cornea changes in 92 patients before and right after they received hyperbaric oxygen therapy for other medical conditions.
What They Found
This observational study of 92 patients found statistically significant changes in three corneal and eye measurements after hyperbaric oxygen therapy. Central corneal thickness decreased slightly, from 529.69 to 526.63 micrometers (p equals 0.002), and corneal volume decreased from 58.63 to 58.21 cubic millimeters (p equals 0.016). Anterior chamber volume increased from 124.38 to 126.42 cubic millimeters (p equals 0.003). When comparing diabetic patients (22) to non-diabetic patients (70), the abstract reports no substantial difference in how much CCT and corneal volume changed between the two groups, though diabetic patients had significantly lower anterior chamber volume before treatment began (p equals 0.01 and p equals 0.042).
What This Means for Canadian Patients
This study does not address whether hyperbaric oxygen therapy helps or is used for any eye condition. It only reports that corneal and anterior chamber measurements shifted slightly during a course of HBOT given for other, non-eye conditions. The abstract does not state whether these measured changes affect vision, comfort, or eye health.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The study measured changes only immediately before and after treatment in a single group without a control arm, so it cannot show whether these corneal changes are temporary, lasting, or caused by HBOT itself rather than other factors.